Mr. Speaker, I would like to reassure Canadians that we are working on this 24/7. When it comes to the approval, it is in our collective interest to resolve this shortage. Industry and professional health care associations must be responsible and continue to work on measures beyond information sharing so that they can create stability in their supply chain and prevent drug shortages.
My department is helping the provinces and the territories by fast-tracking approvals without compromising our high standards of safety and efficacy.